Part 1 obgyn notes Sri Lanka
    NOTES for part 1
    /
    pathology
    /
    6.Neoplasia
    /
    4.Aneuploidy in Cancer

    4.Aneuploidy in Cancer

    Owner
    U
    Untitled
    Verification
    Tags

    1. Definition

    • Aneuploidy = abnormal chromosome number that is not a multiple of the haploid set (23).
    • A normal somatic cell has 46 chromosomes (23 pairs).
    • Aneuploid cell may have 45, 47, or any non-diploid complement.
    • Represents a deviation from normal chromosome complement.

    2. Frequency in Cancers

    • Aneuploidy is very common in malignant tumors → especially carcinomas.
    • First proposed over a century ago as a causal mechanism in cancer.
    • Modern evidence supports active involvement in tumor progression.

    3. Mechanism of Development

    Main mechanism

    • Mitotic checkpoint failure (spindle assembly checkpoint).

    Normal checkpoint role

    • Ensures chromosomes are properly attached to mitotic spindle before anaphase.
    • Prevents premature separation of sister chromatids.
    • Acts as a chromosome gatekeeper controlling equal segregation.

    When checkpoint fails

    • Chromosomes mis-segregate during cell division.
    • Daughter cells receive unequal chromosome numbers.
    • Severe checkpoint failure → catastrophic mis-segregation → usually lethal to cells.

    4. Biological Debate – Cause vs. Consequence

    • Historically unclear whether aneuploidy was:
      • a downstream consequence of cancer or
      • a driver of carcinogenesis.
    • Increasing evidence shows aneuploidy can actively promote cancer.

    How it promotes cancer

    • Chromosome copy number variation → altered gene dosage:
      • ↑ oncogene copies (drive proliferation)
      • ↓ tumor suppressor copies (remove brakes)

    5. Key Gene Dosage Examples

    • Chromosome 8 gain → MYC amplification
      • MYC = potent pro-proliferative transcription factor.
      • Frequently gained, rarely lost in aneuploid cancers.
    • Chromosome 17 loss → TP53 deletion
      • TP53 = major tumor suppressor involved in DNA damage control + apoptosis.
      • Frequently lost, rarely gained.

    6. Mechanistic Sequence Summary

    Mitotic checkpoint failure

    → chromosome mis-segregation

    → abnormal chromosome number (aneuploidy)

    → altered oncogene / tumor suppressor balance

    → ↑ proliferation + ↓ growth control

    → tumor evolution and progression

    7. Conceptual Memory Anchors

    • Checkpoint = Chromosome gatekeeper.
    • Oncogene MYC “multiplies” on chromosome 8.
    • TP53 “tumbles” when chromosome 17 copy lost.
    • Aneuploidy = “library missing or adding books” — disrupts function.

    8. High-Yield Exam Points

    • Aneuploidy is hallmark feature of many cancers.
    • Checkpoint failure = strongest mechanistic link.
    • Complete loss of checkpoint → cell death → tumors retain partial checkpoint dysfunction.
    • Gene dosage imbalance is the mechanism linking aneuploidy to cancer.

    If you'd like, I can now:

    • convert into active recall Q&A tables
    • integrate into your cancer genetics map
    • build SBA/MCQs on this topic
    • give diagrams or flowcharts